Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • seqjordan
    Junior Member
    • Dec 2013
    • 4

    read alignment trimming

    Hi everyone,

    I want to ask the meaning of the following sentence?
    The methylation calls data were aligned using iterative trimming, without trimming any initial bases before alignment.
    How should one do the alignment using bowtie2 or Bismark?
    Thank you a lot!
  • JackieBadger
    Senior Member
    • Mar 2009
    • 385

    #2
    The paper doesn't say?

    Comment

    • seqjordan
      Junior Member
      • Dec 2013
      • 4

      #3
      Originally posted by JackieBadger View Post
      The paper doesn't say?
      Hi Jackie,

      It mentioned: "Based on our M-bias plots we filtered the first 15 bases of each read as part of summarizing the methylation evidence", which means after alignment the first 15 bases are trimmed ? but how does iterative trimming work?
      Thanks!!

      Comment

      • simonandrews
        Simon Andrews
        • May 2009
        • 870

        #4
        Maybe it's just that they did an untrimmed (or only adapter trimmed) alignment using bismark first. They then saw that the M-bias plot produced by bismark showed artefacts at the start of the reads so they then went back and removed some more bases and aligned again to get a more solid set of methylation calls?

        Comment

        • seqjordan
          Junior Member
          • Dec 2013
          • 4

          #5
          Originally posted by simonandrews View Post
          Maybe it's just that they did an untrimmed (or only adapter trimmed) alignment using bismark first. They then saw that the M-bias plot produced by bismark showed artefacts at the start of the reads so they then went back and removed some more bases and aligned again to get a more solid set of methylation calls?
          @simon, you mean after trimming the first 15 bases then do the alignment again? The methylation call are stored into tsv files and then converted back? What I used for alignment is special bowtie2, as described here: https://github.com/BenLangmead/bsmoo..._align.pl#L207
          There is no trimming option in this step. Thank you!

          Comment

          • simonandrews
            Simon Andrews
            • May 2009
            • 870

            #6
            We've certainly trimmed and remapped data after seeing an initial m-bias plot to remove odd looking bases at the start of the reads. We used a small custom script to do this rather than a generic trimmer or trying to do it in the mapper. We could just have ignored the first 15 bases when we extracted the methylation calls, but it was easier to trim and remap, and this would also potentially give us better mapping efficiency if the bias was through the introduction of non-native sequence.

            Comment

            • seqjordan
              Junior Member
              • Dec 2013
              • 4

              #7
              Originally posted by simonandrews View Post
              We've certainly trimmed and remapped data after seeing an initial m-bias plot to remove odd looking bases at the start of the reads. We used a small custom script to do this rather than a generic trimmer or trying to do it in the mapper. We could just have ignored the first 15 bases when we extracted the methylation calls, but it was easier to trim and remap, and this would also potentially give us better mapping efficiency if the bias was through the introduction of non-native sequence.
              If bismark is used then the resulting mean coverage is very high, but when I used bowtie2+bsmooth, the coverage is much lower. Why is this so different?

              Comment

              • simonandrews
                Simon Andrews
                • May 2009
                • 870

                #8
                Without knowing the details of exactly what you ran it's difficult to say. Both bismark and bsmooth use essentially similar processes to map the data so any differences you see will be in the specific options used - they' both using bowtie (or bowtie2) behind the scenes.

                Comment

                Latest Articles

                Collapse

                • SEQadmin2
                  Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
                  by SEQadmin2


                  Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

                  The systematic characterization of the human proteome has
                  ...
                  07-20-2026, 11:48 AM
                • SEQadmin2
                  Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
                  by SEQadmin2



                  Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
                  ...
                  07-09-2026, 11:10 AM
                • SEQadmin2
                  Cancer Drug Resistance: The Lingering Barrier to Rising Survival
                  by SEQadmin2



                  Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

                  There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
                  07-08-2026, 05:17 AM

                ad_right_rmr

                Collapse

                News

                Collapse

                Topics Statistics Last Post
                Started by SEQadmin2, 07-20-2026, 11:10 AM
                0 responses
                9 views
                0 reactions
                Last Post SEQadmin2  
                Started by SEQadmin2, 07-13-2026, 10:26 AM
                0 responses
                30 views
                0 reactions
                Last Post SEQadmin2  
                Started by SEQadmin2, 07-09-2026, 10:04 AM
                0 responses
                41 views
                0 reactions
                Last Post SEQadmin2  
                Started by SEQadmin2, 07-08-2026, 10:08 AM
                0 responses
                26 views
                0 reactions
                Last Post SEQadmin2  
                Working...